Fig. 2
From: LINC00511 accelerated the process of gastric cancer by targeting miR-625-5p/NFIX axis
LINC00511 bound to miR-625-5p a Nuclear–cytoplasmic fractionation was conducted to examine the distribution of LINC00941 nucleolus and cytoplasm. b Data from starBase database predicted possible miRNAs binding with LINC00511. c QRT-PCR assay was carried out to test the expression of miRNAs in GC cell lines. d The potential binding sites between miR-625-5p and LINC00511 was projected by bioinformatics. e The expression of miR-625-5p was tested in HGC27 and BGC823 cells transfected with miR-625-5p inhibitor and miR-625-5p mimics. f QRT-PCR assays were used to test the expression of miR-625-5p in cells transfected with sh-LINC00511#1. g RIP assays were carried out to illustrate that miR-625-5p and LINC00511 coexisted in the RISCs. h Luciferase reporter assays proved LINC00511 could bind to miR-625-5p. *P < 0.05, **P < 0.01